Literature DB >> 12768441

Association study of autoimmune thyroid disease at 5q23-q33 in Japanese patients.

Takashi Akamizu1, Hitomi Hiratani2, Satoshi Ikegami2, Stephen S Rich3, Donald W Bowden4.   

Abstract

As part of a genome scan to locate familial Graves' disease (GD) and Hashimoto's thyroiditis (HT) genes, an autoimmune thyroid disease (AITD) susceptibility locus has recently been identified at 5q31-q33 in a Japanese population. We performed an association study using six microsatellite markers located at this locus in a set of 440 unrelated Japanese AITD patients and 218 Japanese controls. We found significant allelic association between AITD and three markers located in 5q23-q33. GD demonstrated significant associations with two of these markers, while HT did not show significant associations with any markers. Further, when patients with GD were stratified according to clinical manifestations, the association was significantly different from the other subgroup of each category. These findings suggest the presence of susceptible genes of AITD, especially distinct subgroups of GD, in or near 5q23-q33.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12768441     DOI: 10.1007/s10038-003-0017-3

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

1.  The cytotoxic T lymphocyte antigen-4 is a major Graves' disease locus.

Authors:  B Vaidya; H Imrie; P Perros; E T Young; W F Kelly; D Carr; D M Large; A D Toft; M I McCarthy; P Kendall-Taylor; S H Pearce
Journal:  Hum Mol Genet       Date:  1999-07       Impact factor: 6.150

2.  A first trial of retrospective collaboration for positional cloning in complex inheritance: assay of the cytokine region on chromosome 5 by the consortium on asthma genetics (COAG).

Authors:  C Lonjou; K Barnes; H Chen; W O Cookson; K A Deichmann; I P Hall; J W Holloway; T Laitinen; L J Palmer; M Wjst; N E Morton
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

3.  The statistical analysis of mitochondrial DNA polymorphisms: chi 2 and the problem of small samples.

Authors:  D A Roff; P Bentzen
Journal:  Mol Biol Evol       Date:  1989-09       Impact factor: 16.240

4.  Evidence for a locus regulating total serum IgE levels mapping to chromosome 5.

Authors:  D A Meyers; D S Postma; C I Panhuysen; J Xu; P J Amelung; R C Levitt; E R Bleecker
Journal:  Genomics       Date:  1994-09-15       Impact factor: 5.736

5.  Two major genes, linked to HLA and Gm, control susceptibility to Graves' disease.

Authors:  H Uno; T Sasazuki; H Tamai; H Matsumoto
Journal:  Nature       Date:  1981-08-20       Impact factor: 49.962

6.  Cytokine gene polymorphisms in autoimmune thyroid disease.

Authors:  P J Hunt; S E Marshall; A P Weetman; J I Bell; J A Wass; K I Welsh
Journal:  J Clin Endocrinol Metab       Date:  2000-05       Impact factor: 5.958

7.  CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus.

Authors:  H Donner; H Rau; P G Walfish; J Braun; T Siegmund; R Finke; J Herwig; K H Usadel; K Badenhoop
Journal:  J Clin Endocrinol Metab       Date:  1997-01       Impact factor: 5.958

8.  Molecular organization of the cytokine gene cluster, involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5.

Authors:  B H van Leeuwen; M E Martinson; G C Webb; I G Young
Journal:  Blood       Date:  1989-04       Impact factor: 22.113

9.  Trinucleotide repeat polymorphism within the human antithrombin gene (AT3): allele frequency data for three population groups.

Authors:  J S Waye; B Eng; H Y Ni; M A Blajchman; G Carmody
Journal:  Mol Cell Probes       Date:  1994-04       Impact factor: 2.365

10.  CTLA-4 gene polymorphism associated with Graves' disease in a Caucasian population.

Authors:  T Yanagawa; Y Hidaka; V Guimaraes; M Soliman; L J DeGroot
Journal:  J Clin Endocrinol Metab       Date:  1995-01       Impact factor: 5.958

View more
  8 in total

1.  Microsatellite genotyping of chromosome 14q13.2-14q13 in the vicinity of proteasomal gene PSMA6 and association with Graves' disease in the Latvian population.

Authors:  Tatjana Sjakste; Jelena Eglite; Arturs Sochnevs; Mara Marga; Valdis Pirags; Yrjö Collan; Nikolajs Sjakste
Journal:  Immunogenetics       Date:  2004-06-17       Impact factor: 2.846

2.  The -112G>A polymorphism of the secretoglobin 3A2 (SCGB3A2) gene encoding uteroglobin-related protein 1 (UGRP1) increases risk for the development of Graves' disease in subsets of patients with elevated levels of immunoglobulin E.

Authors:  Dimitry A Chistiakov; Natalia V Voronova; Rust I Turakulov; Kirill V Savost'anov
Journal:  J Appl Genet       Date:  2010-12-18       Impact factor: 3.240

3.  beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.

Authors:  Krystian Jazdzewski; Tomasz Bednarczuk; Magdalena Stepnowska; Sandya Liyanarachchi; Krystyna Suchecka-Rachon; Janusz Limon; Krzysztof Narkiewicz
Journal:  Int J Mol Med       Date:  2007-01       Impact factor: 4.101

4.  Immunogenetics of Hashimoto's thyroiditis.

Authors:  Dimitry A Chistiakov
Journal:  J Autoimmune Dis       Date:  2005-03-11

Review 5.  Thyrotropin Receptor Epitope and Human Leukocyte Antigen in Graves' Disease.

Authors:  Hidefumi Inaba; Leslie J De Groot; Takashi Akamizu
Journal:  Front Endocrinol (Lausanne)       Date:  2016-08-23       Impact factor: 5.555

6.  Association between polymorphism within interleukin related genes and Graves' disease: a meta-analysis of 22 case-control studies.

Authors:  Yaqin Tu; Guorun Fan; Tianshu Zeng; Xiong Cai; Wen Kong
Journal:  Oncotarget       Date:  2017-08-10

7.  Linkage Analysis of the Chromosome 5q31-33 Region Identifies JAKMIP2 as a Risk Factor for Graves' Disease in the Chinese Han Population.

Authors:  Jia Li; Weiping Teng; Yang Yu; Xin Hou; Zhongyan Shan
Journal:  Med Sci Monit       Date:  2019-02-23

8.  Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence.

Authors:  Xun Chu; Yan Dong; Min Shen; Lingling Sun; Changzheng Dong; Yi Wang; Beilan Wang; Kaiyue Zhang; Qi Hua; Shijie Xu; Wei Huang
Journal:  BMC Med Genet       Date:  2009-03-13       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.